CRL · News · 20260806N

Market Demand Trends

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-06 · Importance 17 · Surprise 24

Charles River reported improving demand for drug discovery and development services, particularly from biotechnology clients. The Discovery and Safety Assessment (DSA) segment showed a strong recovery, with improved order trends, backlog, and book-to-bill activity. Demand was described as strengthening among both small and mid-sized biotechnology companies and global biopharmaceutical clients.

Key facts

• TradingView reported the 12-month average price target for CRL was raised from $274.85 to $277.92 and that the consensus among 19 analysts is 'Buy' (14 Buy, 4 Hold, 1 Sell). source